Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
US4767761A · kind A · utility
6Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 4, 1987 |
| Grant date | Aug 30, 1988 |
| Priority date | — |
| Expiry date | Nov 4, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having the structure ##STR1## in which R is --CO--Ar--COOR.sub.1 where R.sub.1 is hydrogen or lower alkyl, and pharmaceutical compositions containing the same exhibiting high growth inhibitory activity against methotrexate resistant cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.